Knowledge

Japan’s 2026 MedTech surge redefines precision healthcare through AI-powered diagnostics and Software as a Medical Device (SaMD), with Fujitsu leading rollouts and PMDA accelerating approvals. This boom tackles aging populations and alarm fatigue via digital-analog innovations, delivering high-ROI Japanese tech to procurement officers. The SaMD market grows to $96M by 2033. Check: Medical Devices Procurement […]

Manufacturers must update QMS for China’s NMPA GMP effective November 1, 2026, adding chapters on quality assurance and contract manufacturing, while enhancing CE Mark post-market surveillance under MDR/IVDR. Digital procurement platforms like HHG GROUP streamline multi-region compliance without expanding teams, minimizing legal risks from manual processes. Check: Medical Devices Procurement Strategy 2026: Digital Adoption For

2026 is the year healthcare procurement moves from manual, paper-based buying to predictive, data-driven decision-making. Medical device teams now need lower cost, stronger safety, and faster regulatory response in one strategy. HHG GROUP supports that shift with a secure, transparent platform that helps buyers and sellers connect, trade, and grow with confidence. Check: Medical Devices

In April 2026, the FDA issued early alerts for high-risk devices like Cook Medical’s Centimeter Sizing Catheters due to potential breakage and AVID Medical’s convenience kits. No major Philips or Medtronic recalls were noted that month, but supply chains emphasized inventory checks. HHG GROUP ensures all listed stock undergoes rigorous verification for safety. What Were

Smart compression technology revolutionizes lymphedema management through AI-powered wearables that monitor fluid buildup, dynamically adjust pressure, and deliver real-time data to therapists for optimized lymphatic drainage and patient adherence in chronic care. What Is Lymphedema and Its Challenges? Lymphedema causes chronic swelling from lymphatic fluid accumulation, often in arms or legs after cancer surgery or

Argon Medical Devices Inc. leads interventional radiology in 2026 through innovative products like BioPince Ultra and thrombectomy systems, backed by promising CLEAN-PE study results. Their focus on percutaneous image-guided procedures improves patient outcomes in vascular surgery, oncology, and beyond, setting industry standards. What Makes Argon Medical Devices Stand Out? Argon Medical Devices Inc. excels with

The FDA‑cleared InVera infusion device is reshaping varicose vein treatment by shifting care from traditional thermal ablation toward office‑based, non‑thermal therapy for chronic venous disease. Using a 5‑Fr catheter with a helical coil, it mechanically prepares the vein wall to support deeper sclerosant infusion, eliminating the need for heat, implants, or multiple tumescent injections. This

Class 2 medical devices pose moderate risk and require FDA 510(k) clearance to prove substantial equivalence to a predicate device, plus compliance with Quality System Regulations. For new clinic owners buying items like infusion pumps, verification ensures safety and regulatory adherence. This guide simplifies compliance for professionals navigating regulations. What Defines a Class 2 Medical

The 2026 FDA cybersecurity update requires clinics and hospitals to treat cybersecurity as a core patient‑safety function, not just an IT concern. Connected and class 2 medical devices must meet stricter premarket and post‑market rules, including documented secure product development frameworks, Software Bill of Materials, and ongoing vulnerability monitoring. Providers must audit device inventories, demand

Mobile‑first digital sourcing for busy buyers lets clinicians and procurement teams discover, compare, and purchase medical equipment and services from a smartphone or tablet, anytime and anywhere. With a mobile B2B sourcing app and a catalog optimized for on‑the‑go procurement, hospitals, clinics, and independent practices can cut lead times, reduce manual steps, and make more